Study links dapagliflozin to bladder, breast cancers

06/26/2011 | Reuters

Patients treated with the diabetes drug dapagliflozin may develop certain types of cancer, according to company reports from Bristol-Myers Squibb and AstraZeneca, co-makers of the drug. About nine bladder cancer and nine breast cancer incidences were noted in participants on dapagliflozin therapy, experts said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO